Long Covid is a stable, maladaptive immunometabolic state, not just random leftover damage, and it has big implications for how we design biomarkers and treatments.
Source
You might also wanna read
Microfluidic Assay Quantifies Fibrinaloid Clots in Pediatric Long COVID Patients
This research article presents a study using microfluidic assays to quantify fibrinaloid clots in plasma from pediatric Long COVID patients.
Steroids during acute COVID-19 do not prevent long COVID in children, large RECOVER study finds
This study from the RECOVER Initiative evaluated whether steroid use (dexamethasone, prednisone, prednisolone, methylprednisolone) during ac

Long COVID leads to significant workforce exit and work productivity loss, Dutch cohort study finds
This prospective cohort study (PRIME post-COVID) in the Netherlands assessed workforce exit and work productivity loss among adults with pos

COVID-19 linked to fourfold increased risk of active tuberculosis in Japanese nationwide study
A large-scale Japanese insurance database analysis found that prior COVID-19 infection was associated with a fourfold higher risk of subsequ

Clinical Review: Diagnosis and Management of ME/Chronic Fatigue Syndrome for General Practitioners
This article provides a concise clinical review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) for general internists and pr
Long COVID risk factors identified in large cohort study of 65,000+ U.S. adults
This retrospective cohort study analyzed data from 65,464 U.S. adults in the All of Us Research Program to examine long COVID risk factors.

Comments
Sign in to join the conversation.
No comments yet. Be the first.